Patents by Inventor Lichun Dong

Lichun Dong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods for vaccinating against HSV-2
    Patent number: 7879339
    Abstract: This invention relates to a method for systemic immune activation which is effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in a mammal. The method is particularly effective for protecting a mammal from herpes simplex virus. Also disclosed are therapeutic compositions useful in such a method.
    Type: Grant
    Filed: October 16, 2009
    Date of Patent: February 1, 2011
    Assignees: Vical Incorporated, The University of Washington
    Inventors: Adrian Vilalta, Michal Margalith, Lichun Dong, David Koelle
  • Compositions and Methods for Vaccinating Against HSV-2
    Publication number: 20100160418
    Abstract: This invention relates to a method for systemic immune activation which is effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in a mammal. The method is particularly effective for protecting a mammal from herpes simplex virus. Also disclosed are therapeutic compositions useful in such a method.
    Type: Application
    Filed: October 16, 2009
    Publication date: June 24, 2010
    Applicants: Vical Incorporated, The University of Washington
    Inventors: Adrian Vilalta, Michal Margalith, Lichun Dong, David M. Koelle
  • Compositions and Methods for Vaccinating Against HSV-2
    Publication number: 20100160419
    Abstract: This invention relates to a method for systemic immune activation which is effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in a mammal. The method is particularly effective for protecting a mammal from herpes simplex virus. Also disclosed are therapeutic compositions useful in such a method.
    Type: Application
    Filed: October 16, 2009
    Publication date: June 24, 2010
    Applicants: Vical Incorporated, The University of Washington
    Inventors: Adrian Vilalta, Michal Margalith, Lichun Dong, David M. Koelle
  • Compositions and Methods for Vaccinating Against HSV-2
    Publication number: 20100158949
    Abstract: This invention relates to a method for systemic immune activation which is effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in a mammal. The method is particularly effective for protecting a mammal from herpes simplex virus. Also disclosed are therapeutic compositions useful in such a method.
    Type: Application
    Filed: October 16, 2009
    Publication date: June 24, 2010
    Applicants: VICAL INCORPORATED, THE UNIVERSITY OF WASHINGTON
    Inventors: Adrian Vilalta, Michal Margalith, Lichun Dong, David M. Koelle
  • Compositions and Methods for Vaccinating Against HSV-2
    Publication number: 20100040651
    Abstract: This invention relates to a method for systemic immune activation which is effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in a mammal. The method is particularly effective for protecting a mammal from herpes simplex virus. Also disclosed are therapeutic compositions useful in such a method.
    Type: Application
    Filed: October 23, 2009
    Publication date: February 18, 2010
    Inventors: Adrian Vilalta, Michal Margalith, Lichun Dong, David M. Koelle
  • Compositions and methods for vaccinating against HSV-2
    Patent number: 7628993
    Abstract: This invention relates to a method for systemic immune activation which is effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in a mammal. The method is particularly effective for protecting a mammal from herpes simplex virus. Also disclosed are therapeutic compositions useful in such a method.
    Type: Grant
    Filed: July 20, 2007
    Date of Patent: December 8, 2009
    Assignees: Vical Incorporated, University of Washington
    Inventors: Adrian Vilalta, Michal Margalith, Lichun Dong, David M. Koelle
  • COMPOSITIONS AND METHODS FOR VACCINATING AGAINST HSV-2
    Publication number: 20080102087
    Abstract: This invention relates to a method for systemic immune activation which is effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in a mammal. The method is particularly effective for protecting a mammal from herpes simplex virus. Also disclosed are therapeutic compositions useful in such a method.
    Type: Application
    Filed: July 20, 2007
    Publication date: May 1, 2008
    Applicants: Vical, Incorporated, University of Washington
    Inventors: Adrian Vilalta, Michal Margalith, Lichun Dong, David M. Koelle
  • Method
    Publication number: 20070026015
    Abstract: The invention relates to a method of eliciting a T cell response against a T cell epitope in a host mammalian subject, which method comprises: (i) a first immunisation that comprises at least two administrations which are from 1 to 14 days apart to the subject, wherein each administration comprises administering a nucleotide of interest (NOI) encoding the T cell epitope, and optionally (ii) a second immunisation that comprises at least one administration to the subject of (a) a NOI encoding the T cell epitope, or (b) a protein comprising the T cell epitope, wherein the time between the first administration of the first immunisation, and the first administration of the second immunisation, is from 21 to 365 days.
    Type: Application
    Filed: October 12, 2004
    Publication date: February 1, 2007
    Inventors: Ralph Braun, Lichun Dong